How can I tell if an online compounded semaglutide pharmacy is FDA compliant?

Short answer: There’s no single “FDA stamp” that says a compounded semaglutide pharmacy is fully OK — but you can confirm compliance by checking licenses, registration, third‑party testing, prescribing practices and visible FDA/State inspection status. If the seller can’t or won’t provide the items below, don’t use them.

Step‑by‑step checklist to verify an online compounded semaglutide pharmacy

1. Confirm they’re a licensed pharmacy

• Verify the pharmacy’s state license(s) with your State Board of Pharmacy (use the board’s online license lookup). A legitimate U.S. pharmacy must be licensed in the state where it’s located and in states where it ships, when required.

1. Check NABP/VIPPS and online pharmacy reputation

• Look up the site on the National Association of Boards of Pharmacy (NABP) site and the VIPPS directory (nabp.pharmacy). Avoid sites that aren’t listed and have many consumer complaints.

1. Determine whether they’re a 503A pharmacy or a 503B outsourcing facility

• 503A (traditional compounding pharmacies) compound for individual patients from prescriptions and are primarily overseen by State Boards of Pharmacy.
• 503B outsourcing facilities register with the FDA and are subject to FDA inspections; FDA maintains a searchable list of registered outsourcing facilities. If the seller claims to be a 503B, confirm it on the FDA registry.

1. Ask for certificates-of-analysis (COAs) and sterility testing

• A reputable compounder should provide (on request) independent third‑party COAs documenting identity, potency, purity and sterility (for injectables). Verify dates, lab accreditation and that test results match the product lot you’d receive.

1. Prescription, telemedicine and clinician oversight

• They must require a valid prescription from a U.S.‑licensed clinician (or provide a legitimate telemedicine consult with a U.S. clinician). Sites that ship injectables without a prescription are illegal and dangerous.

1. Cold‑chain handling and traceability

• For injectables like semaglutide, verify how they store and ship (temperature‑controlled packaging), provide lot numbers, and have a documented chain of custody.

1. Check for FDA actions or warning letters

• Search the FDA site for warning letters or safety alerts mentioning the pharmacy or its compounding facility. Prior regulatory action is a red flag.

1. Red flags — if you see any of these, do not buy

• No prescription required, refuses to show state license, no pharmacist contact info, no COAs, impossible low prices, bulk vials without documentation, payment only by crypto, foreign origin with U.S. physician names, or claims that compounded semaglutide is “FDA approved” (compounded versions aren’t approved like brand biologics).

Key resources to use right now

• State Board of Pharmacy (your state): license lookup and complaint filing
• NABP (nabp.pharmacy): VIPPS and verified pharmacy info
• FDA Outsourcing Facility Registry and Warning Letter search
• FDA MedWatch to report adverse events or suspicious outlets

Practical safer alternatives (brands and services)

• Use FDA‑approved semaglutide products (manufactured by Novo Nordisk: Ozempic, Wegovy, Rybelsus) filled at your local licensed pharmacy (CVS, Walgreens, Walmart) or a major online pharmacy — these are manufactured and distributed under FDA oversight.
• If you prefer telemedicine and ongoing care: Calibrate (specialized metabolic/GLP‑1 program), Hims & Hers, Ro, PlushCare and GoodRx Care — these services provide licensed clinician consultations, prescriptions when appropriate, and use licensed pharmacies to dispense. They offer supervised care and are less risky than unknown compounding sites.
• If you must use a compounded product: limit yourself to 503B outsourcing facilities that appear on the FDA’s registry and can show COAs and recent inspection records. Ask for the facility name and check it on the FDA site.

If you suspect a pharmacy is non‑compliant

• Don’t use products from them.
• Report to your State Board of Pharmacy, the NABP/Internet pharmacy complaint portal, and the FDA (MedWatch).

Bottom line A compliant compounder will be transparent: state licenses, FDA/State inspection status (or 503B registration), independent COAs, a required prescription/clinician oversight, and documented cold‑chain and lot traceability. If any of those are missing or they make misleading claims about “FDA approval,” walk away and get treatment through a licensed provider or an FDA‑approved product.